Androgenic Alopecia Clinical Trial
Official title:
Efficacy and Safety of Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality in Patients With Androgenic Alopecia a Take-Home Hair Care Product and an In-Clinic Scalp Stimulating Treatment
The study aims to assess the efficacy and safety of Keravive by Hydrafacial treatments and Keravive Peptide Spray for scalp health and enhancing hair quality in patients with androgenic alopecia. This study is intended to be a single arm study. Suitable subjects who meet all inclusion criteria and consented will undergo 3 in-office Keravive by Hydrafacial treatments at Day 0 and Weeks 4 and 8 in combination with daily application on Keravive Peptide Spray at home. Subjects will be assessed at Day 0, and Weeks 4, 8, and 20 by investigators using the Norwood Scale (males), Ludwig Classification (females), and a series of Likert scales for ranking improvement in scalp health and hair quality.
This study is intended to be a single arm study. Suitable subjects who meet all inclusion criteria and consented will undergo 3 in-office Keravive by Hydrafacial treatments at baseline and Weeks 4 and 8 in combination with daily application on Keravive Peptide Spray at home. Subjects will be assessed at baseline, and Weeks 4, 8, and 20 by investigators using the Norwood Scale (males), Ludwig Classification (females), and a series of Likert scales for ranking improvement in scalp health and hair quality. Efficacy will be assessed through a series of dynamic and static questionnaires. Investigators will complete static questionnaires at Day 0 and Weeks 4, 8 and 20 rating the subjects' hair appearance, thinning, and temporal line recession using Likert scales. Subjects will complete dynamic questionnaires at Weeks 4, 8 and 20 to compare their current state to their baseline condition for scalp symptoms (itchiness, dryness, and flakiness) and hair quality (overall health, fullness, evenness, pigment, hair growth, and hair loss) using Likert scales. Subjects will also rank their hair appearance at Day 0, Week 4, 8, and 20. Photography will be performed at each study visit. Safety assessments will include investigator- and subject-reported adverse events (AEs) during the study. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06110377 -
MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)
|
Phase 4 | |
Recruiting |
NCT05611593 -
Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
|
Phase 1 | |
Completed |
NCT03676400 -
Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia
|
N/A | |
Recruiting |
NCT05938569 -
Computer-Assisted Hair Restoration Study Using ARTAS System
|
N/A | |
Not yet recruiting |
NCT06326359 -
Autologous Stromal Vascular Fraction in Treatment of Male Androgenic Alopecia
|
N/A | |
Recruiting |
NCT05426629 -
Hydraderm for Androgenic Alopecia
|
Phase 4 | |
Recruiting |
NCT05827991 -
A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia
|
N/A | |
Recruiting |
NCT05369481 -
Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia
|
N/A | |
Not yet recruiting |
NCT06292533 -
Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study
|
N/A | |
Completed |
NCT02824380 -
Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
|
Phase 1 | |
Completed |
NCT02594046 -
The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia
|
N/A | |
Recruiting |
NCT05435625 -
Fractional Laser Versus Radiofrequency in Androgenetic Alopecia
|
N/A | |
Completed |
NCT05450861 -
Effect of the Composition From Fish on Promoting Hair Growth
|
N/A | |
Completed |
NCT03506503 -
Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia
|
N/A | |
Completed |
NCT03467412 -
To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
|
Phase 2 | |
Completed |
NCT01852487 -
Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia
|
N/A | |
Not yet recruiting |
NCT03474718 -
Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia
|
Early Phase 1 | |
Active, not recruiting |
NCT02914587 -
Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study
|
N/A | |
Completed |
NCT04341363 -
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
|
N/A | |
Completed |
NCT04450602 -
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
|
N/A |